ORLANDO, Fla. – As the U.S. prepares for a decision later this week on the Johnson & Johnson vaccine, the European Union’s drug regulatory agency found a “possible link” between the vaccine and rare clots though the agency said the benefits outweigh the risks.
The agency recommended J&J add a warning label to the vaccine and also said the problems should be considered “very rare side effects of the vaccine,” according to the Associated Press. [TRENDING: Fla. ‘witch’ swindles $100K from victims | Nation reacts to verdict in George Floyd death | What ingredients make a vaccine?] European officials said they considered all available evidence from the U.S., which ultimately consisted of eight cases, including one death.